Mizuho lowered the firm’s price target on Staar Surgical to $65 from $85 and keeps a Buy rating on the shares. The analyst updated medtech and diagnostics price targets ahead of the Q2 reporting season.
Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See the top stocks recommended by analysts >>
Read More on STAA: